Cargando…
The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450277/ https://www.ncbi.nlm.nih.gov/pubmed/34547366 http://dx.doi.org/10.1016/j.kint.2021.09.006 |
| _version_ | 1784569604336517120 |
|---|---|
| author | Pedersen, Rune M. Bang, Line L. Tornby, Ditte S. Kierkegaard, Helene Nilsson, Anna C. Johansen, Isik S. Bistrup, Claus Jensen, Thøger G. Justesen, Ulrik S. Andersen, Thomas E. |
| author_facet | Pedersen, Rune M. Bang, Line L. Tornby, Ditte S. Kierkegaard, Helene Nilsson, Anna C. Johansen, Isik S. Bistrup, Claus Jensen, Thøger G. Justesen, Ulrik S. Andersen, Thomas E. |
| author_sort | Pedersen, Rune M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8450277 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84502772021-09-20 The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine Pedersen, Rune M. Bang, Line L. Tornby, Ditte S. Kierkegaard, Helene Nilsson, Anna C. Johansen, Isik S. Bistrup, Claus Jensen, Thøger G. Justesen, Ulrik S. Andersen, Thomas E. Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-11 2021-09-20 /pmc/articles/PMC8450277/ /pubmed/34547366 http://dx.doi.org/10.1016/j.kint.2021.09.006 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Pedersen, Rune M. Bang, Line L. Tornby, Ditte S. Kierkegaard, Helene Nilsson, Anna C. Johansen, Isik S. Bistrup, Claus Jensen, Thøger G. Justesen, Ulrik S. Andersen, Thomas E. The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title | The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title_full | The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title_fullStr | The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title_full_unstemmed | The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title_short | The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine |
| title_sort | sars-cov-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the bnt162b2 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450277/ https://www.ncbi.nlm.nih.gov/pubmed/34547366 http://dx.doi.org/10.1016/j.kint.2021.09.006 |
| work_keys_str_mv | AT pedersenrunem thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT banglinel thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT tornbydittes thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT kierkegaardhelene thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT nilssonannac thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT johansenisiks thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT bistrupclaus thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT jensenthøgerg thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT justesenulriks thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT andersenthomase thesarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT pedersenrunem sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT banglinel sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT tornbydittes sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT kierkegaardhelene sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT nilssonannac sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT johansenisiks sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT bistrupclaus sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT jensenthøgerg sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT justesenulriks sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine AT andersenthomase sarscov2neutralizingcapacityofkidneytransplantrecipients4weeksafterreceivingaseconddoseofthebnt162b2vaccine |